Evidence map›Paper›PMID 29864031›Full record

ArticleThe Journal of clinical investigation2018

Neuronatin regulates pancreatic β cell insulin content and secretion.

Steven J Millership, Gabriela Da Silva Xavier, Agharul I Choudhury, Sergio Bertazzo, Pauline Chabosseau, Silvia Ma Pedroni, Elaine E Irvine, Alex Montoya, Peter Faull, William R Taylor and 10 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. PARN Maintains RNA Stability to Regulate Insulin Maturation and GSIS in Pancreatic β Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. The MODY-associatedeLife · 2024
    Article
  11. Differential CpG methylation atbioRxiv : the preprint server for biology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Steven J MillershipMRC London Institute of Medical Sciences, London, United Kingdom.
Gabriela Da Silva XavierSection of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Agharul I ChoudhuryMRC London Institute of Medical Sciences, London, United Kingdom.
Sergio BertazzoDepartment of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
Pauline ChabosseauSection of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
Silvia Ma PedroniMRC London Institute of Medical Sciences, London, United Kingdom.
Elaine E IrvineMRC London Institute of Medical Sciences, London, United Kingdom.
Alex MontoyaMRC London Institute of Medical Sciences, London, United Kingdom.
Peter FaullMRC London Institute of Medical Sciences, London, United Kingdom.
William R TaylorComputational Cell and Molecular Biology Laboratory, Francis Crick Institute, London, United Kingdom.
Julie Kerr-ConteEuropean Genomic Institute for Diabetes, UMR 1190 Translational Research for Diabetes, INSERM, CHU Lille, University of Lille, Lille, France.
Francois PattouEuropean Genomic Institute for Diabetes, UMR 1190 Translational Research for Diabetes, INSERM, CHU Lille, University of Lille, Lille, France.
Jorge FerrerBeta Cell Genome Regulation Laboratory, Department of Medicine, Imperial College London, London, United Kingdom.
Mark ChristianInstitute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Rosalind M JohnSchool of Biosciences, Cardiff University, Cardiff, United Kingdom.
Mathieu LatreilleMRC London Institute of Medical Sciences, London, United Kingdom.
Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Guy A RutterSection of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, United Kingdom.
James ScottNational Heart and Lung Institute, Department of Medicine, Imperial College London, London, United Kingdom.
Dominic J WithersMRC London Institute of Medical Sciences, London, United Kingdom.
MRC London Institute of Medical Sciences · GBGenomics (United Kingdom) · GBImperial College London · GBInserm · FRCardiff University · GBLung Institute · USThe Francis Crick Institute · GBTianjin Medical University General Hospital · CNUniversity College London · GB

Funding

Medical Research Council MC_U120097114Medical Research Council MC_UP_1102/15Medical Research Council MR/K001981/1Medical Research Council MR/K023667/1Medical Research Council MR/L020149/1Medical Research Council MR/L02036X/1Medical Research Council MR/M012646/1Medical Research Council MR/N00275X/1Medical Research Council MR/N020472/1Medical Research Council MR/R010676/1Wellcome Trust FC001179
6 · The paper itself

Abstract

Neuronatin (Nnat) is an imprinted gene implicated in human obesity and widely expressed in neuroendocrine and metabolic tissues in a hormone- and nutrient-sensitive manner. However, its molecular and cellular functions and precise role in organismal physiology remain only partly defined. Here we demonstrate that mice lacking Nnat globally or specifically in β cells display impaired glucose-stimulated insulin secretion leading to defective glucose handling under conditions of nutrient excess. In contrast, we report no evidence for any feeding or body weight phenotypes in global Nnat-null mice. At the molecular level neuronatin augments insulin signal peptide cleavage by binding to the signal peptidase complex and facilitates translocation of the nascent preprohormone. Loss of neuronatin expression in β cells therefore reduces insulin content and blunts glucose-stimulated insulin secretion. Nnat expression, in turn, is glucose-regulated. This mechanism therefore represents a novel site of nutrient-sensitive control of β cell function and whole-animal glucose homeostasis. These data also suggest a potential wider role for Nnat in the regulation of metabolism through the modulation of peptide processing events.

Indexed as

Gene Expression RegulationInsulin SecretionAnimalsGlucoseInsulinInsulin-Secreting CellsMembrane ProteinsMiceMice, TransgenicNerve Tissue ProteinsGlucoseInsulinMembrane ProteinsNerve Tissue ProteinsNnat protein, mouseBeta cellsCell BiologyDiabetesGeneticsInsulin

Identifiers

PMID29864031
PMCPMC6063487
OpenAlexW2807680227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.